Loss of Nephrin Expression in Glomeruli of Kidney-Transplanted Patients Under m-TOR Inhibitor Therapy
Loss of Nephrin Expression in Glomeruli of Kidney-Transplanted Patients Under m-TOR Inhibitor Therapy
复制标题
DOI:
10.1111/j.1600-6143.2010.03259.x
复制
发表时间:
2010-10-01
影响因子:
8.8
通讯作者:
Segoloni, G. P.
中科院分区:
文献类型:
--
作者:
Biancone, L.;Bussolati, B.;Segoloni, G. P.
The development of proteinuria has been observed in kidney-transplanted patients on m-TOR inhibitor (m-TORi) treatment. Recent studies suggest that m-TORi(s) may alter the behavior and integrity of glomerular podocytes. We analyzed renal biopsies from kidney-transplanted patients and evaluated the expression of nephrin, a critical component of the glomerular slit-diaphragm. In a group of patients on 'de novo' m-TORi-treatment, the expression of nephrin within glomeruli was significantly reduced in all cases compared to pretransplant donor biopsies. Biopsies from control transplant patients not treated with m-TORi(s) failed to present a loss of nephrin. In a group of patients subsequently converted to m-TORi-treatment, a protocol biopsy performed before introduction of m-TORi was also available. The expression of nephrin in the pre-m-TORi biopsies was similar to that observed in the pretransplant donor biopsies but was significantly reduced after introduction of m-TORi(s). Proteinuria increased after the m-TORi inititiation in this group. However, in some cases proteinuria remained normal despite reduction of nephrin. In vitro, sirolimus downregulated nephrin expression by human podocytes. Our results suggest that m-TORi(s) may affect nephrin expression in kidney-transplanted patients, consistently with the observation in vitro on cultured podocytes.